Showing 11,881 - 11,900 results of 74,781 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.93s Refine Results
  1. 11881
  2. 11882
  3. 11883
  4. 11884

    Targeted AAV5-Smad7 gene therapy inhibits corneal scarring <i>in vivo</i> by Suneel Gupta (3860230)

    Published 2017
    “…We demonstrate that a single topical application of AAV5-Smad7 in rabbit cornea post-PRK led to a significant decrease in corneal haze and corneal fibrosis. …”
  5. 11885

    Motor neurons in the cervical spinal cord of G93A mice at early and late stage of disease (cresyl violet staining). by Svitlana Garbuzova-Davis (81764)

    Published 2013
    “…In G93A mice, numerous motor neurons with vacuolization (asterisks) were found at (C) 13 weeks of age and (D) decreased numbers of motor neurons were noted in 17–18 week old mice. …”
  6. 11886

    Image_2_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  7. 11887

    Image_3_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  8. 11888

    Table_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.PDF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  9. 11889

    Image_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  10. 11890

    Image_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  11. 11891

    Table_1_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.PDF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  12. 11892

    Image_3_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  13. 11893

    Image_2_SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.TIF by Yue Liu (292931)

    Published 2020
    “…Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. …”
  14. 11894

    Mean histopathological severity scores in control, paraquat and MPTP-treated groups of C57BL/6J male mice. by Richard Jay Smeyne (3278886)

    Published 2016
    “…Serial sections through the SNpc were evaluated qualitatively and the group mean severity grades are plotted. Grades 0 to 5 reflect increasing intensity of staining for Iba-1, AmCuGg, GFAP and decreased staining intensity of TH.…”
  15. 11895
  16. 11896

    Pre-incubation of SB105-A10 either with HIV-1<sub>IIIb</sub> or HIV-1<sub>ada</sub> strains inhibits the viral infectivity in dilution assay. by Isabella Bon (467395)

    Published 2013
    “…<p>HIV-1 strains were incubated for 1 hour at 37°C with SB105-A10 (20 µg/ml; 4.2 µM). Following this incubation the samples were diluted 50-fold to reduce dendrimer concentrations to a level below that at which SB105-A10 significantly inhibits HIV replication and challenged with activated PBMCs. …”
  17. 11897

    Study characteristics–Indirect pathway. by Silvia Bhatt Carreno (18176553)

    Published 2024
    “…</p><p>Results</p><p>We identified 86 publications that fit inclusion criteria. …”
  18. 11898

    PRISMA flow chart. by Silvia Bhatt Carreno (18176553)

    Published 2024
    “…</p><p>Results</p><p>We identified 86 publications that fit inclusion criteria. …”
  19. 11899

    Inclusion criteria. by Silvia Bhatt Carreno (18176553)

    Published 2024
    “…</p><p>Results</p><p>We identified 86 publications that fit inclusion criteria. …”
  20. 11900

    Quality assessment. by Silvia Bhatt Carreno (18176553)

    Published 2024
    “…</p><p>Results</p><p>We identified 86 publications that fit inclusion criteria. …”